Abstract
Myeloproliferative neoplasms (MPN) are clonal hematological malignancies that are frequently associated with an acquired somatic mutation in JAK2 (JAK2V617F). Patients with MPN are at a high risk of developing thrombotic events. Endothelial cell (EC) abnormalities are thought to contribute to this prothrombotic state. Budd–Chiari syndrome (BCS) and portal vein thromboses have been reported to be associated with JAK2V617F positive hematopoiesis. We explored whether JAK2V617F was present in ECs within the vessels of polycythemia vera (PV) patients with BCS using laser-capture microdissection followed by nested PCR or real-time RT-PCR. The presence of JAK2V617F in both ECs and hematopoietic cells belonging to BCS patients with PV indicates that ECs from these patients are involved by the malignant process and that in this subpopulation of patients the disease may originate from a cell common to hematopoietic and endothelial cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Tefferi A, Elliott M. (2007) Thrombosis in myeloproliferative disorders: prevalence, prognostic factors, and the role of leukocytes and JAK2V617F. Semin Thromb Hemost 33, 313–320.
Wolanskyj AP, Schwager SM, McClure RF, Larson DR, Tefferi A. (2006) Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors. Mayo Clin Proc 159–66.
Finazzi G, Rambaldi A, Guerini V, Carobbo A, Barbui T. (2007) Risk of thrombosis in patients with essential thrombocythemia and polycythemia vera according to JAK2 V617F mutation status. Haematologica. 92,135–136.
Robertson B, Urquhart C, Ford I, et al (2007). Platelet and coagulation activation markers in myeloproliferative diseases: relationships with JAK2 V6I7 F status, clonality, and antiphospholipid antibodies. J Thromb Haemost. 5, 1679–1685.
Bellucci S, Michiels JJ. (2006) The role of JAK2 V617F mutation, spontaneous erythropoiesis and megakaryocytopoiesis, hypersensitive platelets, activated leukocytes, and endothelial cells in the etiology of thrombotic manifestations in polycythemia vera and essential thrombocythemia. Semin Thromb Hemost. 32, 381–398.
Duda DG, Fukumura D, Jain RK. (2004) Role of eNOS in neovascularization: NO for endothelial progenitor cells. Trends Mol Med. 10, 143–145.
Kiladjian JJ, Cervantes F, Leebeek FW, et al. (2008) The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases. Blood. 111, 4922–4929.
Patel RK, Lea NC, Heneghan MA, et al. (2006) Prevalence of the Activating JAK2 Tyrosine Kinase Mutation V617F in the Budd-Chiari Syndrome. Gastroenterology. 130, 2031–2038.
Espina V, Wulfkuhle JD, Calvert V. et al. (2006) Laser-capture microdissection. Nature Protocols. Nat Protoc. 1, 586–603.
Sozer S, Fiel MI, Schiano T, et al. (2009) The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome. Blood. 113, 5246–5249.
Zengin E, Chalajour F, Gehling UM, et al. (2006) Vascular wall resident progenitor cells: a source for postnatal vasculogenesis. Development. 133, 1543–1551.
Ergun S, Tilki D, Hohn HP, Gehling U, Kilic N. (2007) Potential implications of vascular wall resident endothelial progenitor cells. Thromb Haemost. 98, 930–939.
Masuda N, Ohnishi T, Kawamoto S, Monden M, Okubo K. (1999) Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples. Nucleic Acids Res. 27, 4436–4443.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Sozer, S., Hoffman, R. (2011). Laser-Capture Microdissection and Analysis of Liver Endothelial Cells from Patients with Budd–Chiari Syndrome. In: Murray, G. (eds) Laser Capture Microdissection. Methods in Molecular Biology, vol 755. Humana Press. https://doi.org/10.1007/978-1-61779-163-5_34
Download citation
DOI: https://doi.org/10.1007/978-1-61779-163-5_34
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-162-8
Online ISBN: 978-1-61779-163-5
eBook Packages: Springer Protocols